Personal Injury Lawyer Blog Providing
Info in Miami & Nationwide

"Colson Hicks Eidson is recognized as one of the top litigation firms in the country, handling local, national and international litigation for a wide range of clients." - Chambers USA


If You Were Exposed To Water At Marine Corps Base Camp Lejeune In North Carolina, Submit Your Information By Clicking Here. Or Contact Us At: 305-476-7400

What Should I Do If I Was Harmed after Taking Pradaxa?

March 11, 2014
Colson Hicks Eidson

Drug manufacturers must exercise reasonable care in the labeling, manufacturing and dissemination of vital information to doctors and pharmacists concerning the risks of their products.

If you have been injured by Pradaxa, you may be entitled to hold Boehringer Ingelheim accountable in a court of law. When you are harmed by a dangerous drug, it is important to consult with an experienced pharmaceutical litigation attorney as soon as possible to see what options are available to you.

Boehringer Ingelheim Attempted to Cover Up Negative Pradaxa Information

According to The New York Times, the makers of blood-thinning drug Pradaxa were so concerned that an internal research paper would damage drug sales that some employees suggested the entire story should be retracted and nullified completely.

The unsealed legal documents were made public by a federal judge in Illinois who is overseeing thousands of lawsuits filed by individuals who say Pradaxa’s manufacturer, Boehringer Ingelheim, failed to properly warn them about the risks of taking the drug, including fatal bleeding.

Many of the documents released by the Illinois judge centered on whether a coming research paper would undercut the fact that Pradaxa does not require regular blood tests to ensure it is working, one of the drug’s main selling points. Testing is a critical issue because Pradaxa and two other recently approved drugs, Xarelto and Eliquis, are in a race to gain market share from warfarin, a generic drug that for decades has been the standard treatment for preventing blood clots and strokes.

The documents show that Boehringer Ingelheim employees openly fretted when it appeared that the results of the research paper indicated that some patients could benefit from monitoring their blood. The paper found that a certain segment of patients absorb too little of the drug to effectively prevent strokes, while another group absorbs so much that they are at a higher risk for bleeding.

Many say the newly-released documents show that drug makers and regulators had been too eager to approve such powerful drugs without more careful monitoring.

Looking for an Attorney that Handles Pharmaceutical Litigation?

As injury attorney Julie Braman Kane explains in the video above, at Colson Hicks Eidson, we are available to help if you suffered injuries or a loved one suffered a wrongful death due to a negligent manufacturer. Speak with one of our attorneys today at 305-476-7400 for a free consultation to discuss your ability to pursue compensation.

Did You Know: Pradaxa has been prescribed to 850,000 patients, but has also been linked to more than 1,000 deaths.

Colson Hicks Eidson – Injury Attorneys